pyrimidinones and Diseases-in-Twins

pyrimidinones has been researched along with Diseases-in-Twins* in 1 studies

Other Studies

1 other study(ies) available for pyrimidinones and Diseases-in-Twins

Article	Year
Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy. The Pediatric infectious disease journal, 2009, Volume: 28, Issue:12 We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period. Topics: Diseases in Twins; Electrocardiography; Female; Heart; Heart Block; Heart Diseases; HIV Protease Inhibitors; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Lopinavir; Pyrimidinones; Ritonavir; Twins	2009

Article

Year

Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy.

The Pediatric infectious disease journal, 2009, Volume: 28, Issue:12

We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.

Topics: Diseases in Twins; Electrocardiography; Female; Heart; Heart Block; Heart Diseases; HIV Protease Inhibitors; Humans; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Lopinavir; Pyrimidinones; Ritonavir; Twins

2009